Greenwich Lifesciences Stock Price on December 14, 2024
| GLSI Stock | USD 13.51 0.30 2.27% |
Below is the normalized historical share price chart for Greenwich Lifesciences extending back to September 25, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Greenwich Lifesciences stands at 13.51, as last reported on the 14th of December 2024, with the highest price reaching 13.73 and the lowest price hitting 13.20 during the day.
If you're considering investing in Greenwich Stock, it is important to understand the factors that can impact its price. Greenwich Lifesciences holds Efficiency (Sharpe) Ratio of -0.0189, which attests that the entity had a -0.0189% return per unit of risk over the last 3 months. Greenwich Lifesciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Greenwich Lifesciences' Standard Deviation of 3.1, market risk adjusted performance of (0.01), and Risk Adjusted Performance of (0.0002) to validate the risk estimate we provide.
As of now, Greenwich Lifesciences' Sale Purchase Of Stock is decreasing as compared to previous years. . As of now, Greenwich Lifesciences' Price Book Value Ratio is increasing as compared to previous years. The Greenwich Lifesciences' current Price To Book Ratio is estimated to increase to 21.18, while Price Earnings Ratio is projected to decrease to (15.96). Greenwich Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of September 2020 | 200 Day MA 14.6742 | 50 Day MA 13.6494 | Beta 3.318 |
Greenwich |
Sharpe Ratio = -0.0189
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GLSI |
Estimated Market Risk
| 3.06 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Greenwich Lifesciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Greenwich Lifesciences by adding Greenwich Lifesciences to a well-diversified portfolio.
Price Book 35.6404 | Book Value 0.522 | Enterprise Value 171.8 M | Enterprise Value Ebitda (21.23) | Shares Float 5.9 M |
Related Headline
Eyenovia Headline on 13th of December 2024
Eyenovia Receives Delisting Notice from Nasdaq Due to Low St... by thelincolnianonline.com
Eyenovia, Inc. recently disclosed in an 8-K filing that it has received a notification from Nasdaq regarding the delisting of its common stock due to a significant drop in price. The notification, received on December 12, 2024, stated that as of December 11, 2024, Eyenovias common stock had a closing bid price of 0.10
Greenwich Lifesciences Valuation on December 14, 2024
It is possible to determine the worth of Greenwich Lifesciences on a given historical date. On December 14, 2024 Greenwich was worth 13.26 at the beginning of the trading date compared to the closed value of 13.51. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Greenwich Lifesciences stock. Still, in general, we apply an absolute valuation method to find Greenwich Lifesciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Greenwich Lifesciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Greenwich Lifesciences' related companies.
| Open | High | Low | Close | Volume | |
| 13.21 | 13.56 | 13.21 | 13.21 | 19,942 | |
12/13/2024 | 13.26 | 13.73 | 13.20 | 13.51 | 25,916 |
| Backtest Greenwich Lifesciences | | | Greenwich Lifesciences History | | | Greenwich Lifesciences Valuation | Previous |
Greenwich Lifesciences Trading Date Momentum on December 14, 2024
| On December 13 2024 Greenwich Lifesciences was traded for 13.51 at the closing time. The top price for the day was 13.73 and the lowest listed price was 13.20 . The trading volume for the day was 25.9 K. The trading history from December 13, 2024 did not cause price change. The overall trading delta against the current closing price is 1.85% . |
Greenwich Lifesciences Fundamentals Correlations and Trends
By evaluating Greenwich Lifesciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Greenwich Lifesciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Greenwich financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Greenwich Lifesciences Stock history
Greenwich Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Greenwich is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Greenwich Lifesciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Greenwich Lifesciences stock prices may prove useful in developing a viable investing in Greenwich Lifesciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.8 M | 13.8 M | |
| Net Loss | -4.1 M | -4.3 M |
Greenwich Lifesciences Stock Technical Analysis
Greenwich Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Greenwich Lifesciences Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Greenwich Lifesciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Greenwich Lifesciences December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Greenwich Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Greenwich Lifesciences shares will generate the highest return on investment. By undertsting and applying Greenwich Lifesciences stock market strength indicators, traders can identify Greenwich Lifesciences entry and exit signals to maximize returns
Greenwich Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Greenwich Lifesciences' price direction in advance. Along with the technical and fundamental analysis of Greenwich Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Greenwich to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.0002) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | (0.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Greenwich Stock analysis
When running Greenwich Lifesciences' price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |